LH · 10-Q · 2026Q2 · Full report

Capital Return Program

LABCORP HOLDINGS INC. · 2026-08-05 · Importance 65 · Surprise 60 · In source text

Labcorp repurchased $251.8 million more common stock during the first six months of 2026 than in the comparable 2025 period. The Board had authorized $378.6 million of remaining repurchases at June 30, 2026, then approved an additional $1,000.0 million on July 8, bringing total authorization to $1,378.6 million with no expiration date. The company paid $119.9 million of common-stock dividends during the first six months. On July 9, Labcorp declared a $0.72-per-share dividend totaling approximately $59.0 million, payable September 11, 2026.

Key facts

• On July 8, 2026, the Board authorized the repurchase of an additional $1,000.0 in the maximum value of the Company’s shares, bringing the total share repurchase authorization to $1,378.6 maximum value of shares of Common Stock. source
• At June 30, 2026, the Company had outstanding authorization from its Board to purchase up to $378.6 maximum value of Common Stock. source
• On July 9, 2026, the Company announced a cash dividend of $0.72 per share of Common Stock, or approximately $59.0 in the aggregate, payable on September 11, 2026 to stockholders of record as of August 28, 2026. source
• The repurchase authorization has no expiration date. source
• For the six months ended June 30, 2026, the Company paid $119.9 in Common Stock dividends. source

Impact estimates